Division of General Surgery, Dalhousie University, Halifax, NS, B3H 2Y9, Canada.
Sci Rep. 2021 Mar 22;11(1):6509. doi: 10.1038/s41598-021-85885-0.
Transanal endoscopic microsurgery (TEM) is widely used for the excision of rectal adenomas and early rectal adenocarcinoma. Few recommendations currently exist for surveillance of lesions excised by TEM. The purpose of this study was to review the surveillance practices and the patterns of recurrence among TEM resected lesions at a tertiary care hospital. A retrospective chart review was performed on all patients who underwent TEM for rectal adenoma or adenocarcinoma before June 2017. In our study population of 114 patients, the final pathology included 78 (68%) adenomas and 36 (32%) adenocarcinomas. Of the adenocarcinomas 23, 9, and 4 were T1, T2, T3 lesions, respectively. Of those, 25 patients opted for surveillance instead of further treatment. The most commonly recommended endoscopic surveillance strategy by our group for both adenomas and adenocarcinomas excised by TEM was flexible sigmoidoscopy every 6 months for 2 years. Recurrences occurred in 4/78 (5.1%) adenoma patients, all found within 16.9 months of surgery, and in 4/25 (16%) adenocarcinoma patients, found between 7.4 and 38.5 months post-surgery. Our data highlights the fact that the timing of recurrences post TEM surgery is variable. Further studies looking at recurrence patterns are needed in order to create comprehensive guidelines for surveillance of these patients.
经肛门内镜微创手术(TEM)广泛用于直肠腺瘤和早期直肠腺癌的切除。目前几乎没有关于 TEM 切除病变的监测建议。本研究旨在回顾一家三级保健医院 TEM 切除病变的监测实践和复发模式。对所有于 2017 年 6 月前接受 TEM 治疗直肠腺瘤或腺癌的患者进行了回顾性图表审查。在我们的 114 例患者人群中,最终病理学包括 78 例(68%)腺瘤和 36 例(32%)腺癌。23 例腺癌中,9 例和 4 例分别为 T1、T2、T3 病变。其中,25 例患者选择监测而不是进一步治疗。我们组对 TEM 切除的腺瘤和腺癌最常推荐的内镜监测策略是在 2 年内每 6 个月进行乙状结肠镜检查。78 例腺瘤患者中有 4 例(5.1%)发生复发,均在术后 16.9 个月内发现;25 例腺癌患者中有 4 例(16%)发生复发,发现时间为术后 7.4 至 38.5 个月。我们的数据强调了 TEM 手术后复发时间的多变性。需要进一步研究复发模式,以便为这些患者的监测制定综合指南。